Literature DB >> 1658670

Influence of ciclosporin A on renal tubular function after kidney transplantation.

P Heering1, B Grabensee.   

Abstract

There are typical morphological indicators of tubular defects during the administration of ciclosporin A (CSA). Distal tubular function remains unclear although hyperkalemia is a common clinical feature in these patients. We performed renal function studies 3 months after renal transplantation on 35 patients (group 1) treated with CSA. The results were compared to those of a control group consisting of 15 patients transplanted earlier and treated with azathioprine (group 2). Only patients with stable renal function (creatinine less than or equal to 2.0 mg/dl) entered the investigation consisting of: inulin (In) clearance; p-aminohippuric acid (PAH) clearance; ammonium chloride loading; sodium sulfate loading, and sodium bicarbonate loading. Plasma renin activity and aldosterone were measured basally and after stimulation with 40 mg i.v. furosemide. Clearances of In and PAH were significantly impaired during the administration of CSA. Group 1: CIn 73.3 +/- 8.7 ml/min/1.73 m2 (p less than 0.01), CPAH 263 +/- 58.3 ml/min/1.73 m2 (p less than 0.01); group 2: CIn 89.6 +/- 19.1 ml/min/1.73 m2, CPAH 338.7 +/- 63.5 ml/min/1.73 m2. Incomplete distal tubular acidosis could be demonstrated in 8 patients from group 1 but none of group 2. Hyporeninemic hypoaldosteronism could be demonstrated in 4 patients during the administration of CSA. CSA in therapeutic doses significantly impairs renal perfusion, glomerular filtration, distal acidification and the renin-aldosterone axis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658670     DOI: 10.1159/000186520

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

Review 1.  Drug-induced hyperkalemia.

Authors:  Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

2.  Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Authors:  Ludwig Stapenhorst; Robert Sassen; Bodo Beck; Norbert Laube; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

Review 3.  Prevention and management of the adverse effects associated with immunosuppressive therapy.

Authors:  S J Rossi; T J Schroeder; S Hariharan; M R First
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

4.  Nephrotoxicity of cyclosporine in humans: effect of cyclosporine on glomerular filtration and proximal tubular reabsorption.

Authors:  P Heering; P Schadewaldt; D Bach; B Grabensee
Journal:  Clin Investig       Date:  1993-12

Review 5.  Ammonia transport in the kidney by Rhesus glycoproteins.

Authors:  I David Weiner; Jill W Verlander
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

6.  Cyclosporine: a review.

Authors:  Dustin Tedesco; Lukas Haragsim
Journal:  J Transplant       Date:  2012-01-04

7.  Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.

Authors:  Jean-Philippe Bertocchio; Coralie Barbe; Sylvie Lavaud; Olivier Toupance; Pierre Nazeyrollas; Frederic Jaisser; Philippe Rieu
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.